Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QUITSPIT study of oral glycopyrronium bromide for nocturnal clozapine-induced sialorrhea
NL-OMON39699Phase 3Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of glycopyrronium in hypersalivation (3 arms), sponsored by University Medical Center Utrecht. Started Apr 2013; status: active, not recruiting.
02
Drugs
glycopyrronium
03
Conditions
hypersalivation
Beyond the preview
Go deeper on NL-OMON39699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39699.